LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $815,000 | -15.9% | 8,550 | -1.3% | 0.04% | -17.0% |
| Q2 2020 | $969,000 | +48.2% | 8,660 | -3.7% | 0.05% | +27.0% |
| Q1 2020 | $654,000 | -30.2% | 8,989 | 0.0% | 0.04% | +5.7% |
| Q4 2019 | $937,000 | +2.3% | 8,989 | -2.3% | 0.04% | -7.9% |
| Q3 2019 | $916,000 | -13.0% | 9,203 | -0.2% | 0.04% | -7.3% |
| Q2 2019 | $1,053,000 | -9.5% | 9,224 | -0.3% | 0.04% | -12.8% |
| Q1 2019 | $1,163,000 | +11.1% | 9,251 | +19.8% | 0.05% | +113.6% |
| Q4 2018 | $1,047,000 | – | 7,719 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |